Clinical Trial Update: Cysteine Supplementation in Critically Ill Neonates [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for cysteine supplementation in critically ill neonates spanning Phase 2 and Phase 3, with multiple neonatal conditions under investigatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Necrotizing Enterocolitis
• Retinopathy of Prematurity
• Sepsis
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• L-cysteine (L-cysteine)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Sepsis, Bronchopulmonary Dysplasia | Phase 2, Phase 3 | Status: UNKNOWN